An in vitro model of allogeneic stimulation of cord blood: Induction of Fas independent apoptosis

Human Immunology

Volumn 60, Issue 7, 1999, Pages 598-607

  El Ghalbzouri, A ^b   Drenou B ^a   Blancheteau, V ^a   Choqueux, C ^b   Fauchet, R ^a   Charron, D ^a   Mooney, N ^b  

^a INSERM   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; Cord blood; Fas; MHC class I

Indexed keywords

CD3 ANTIGEN; FAS ANTIGEN; FAS LIGAND; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FETAL BLOOD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL;

EID: 0344603639     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00040-3     Document Type: Article

References (30)

1. Gluckman E., Vanderson R., Boyer-Chammard A., Locatelli F., Arcese W., Pasquini R., Ortega J., Souillet G., Ferreira E., Laporte J.P., Fernandez M., Chastang C. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 337:1997;373.
2. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkovitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., Stevens C.E. outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 339:1998;1565.
3. Brugnoni D., Airo P., Graf D., Marconi M., Lebowitz M., Plebani A., Giliani S., Malacarne F., Cattaneo R., Ugazio A.G., Albertini A., Kroczek R.A., Notarangelo L.D. Ineffective expression, of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol. 24:1994;1919.
4. Fuleihan R., Ahern D., Geha R. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol. 24:1994;1925.
5. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., Deluca D., Schenker L., Bard J., Boyse E.A. Phenotypic and functionnal immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci. 89:1992;10006.
6. Garban F., Ericson M., Roucard C., Rabian-Herzog C., Teisserenc H., Sauvanet E., Charron D., Mooney N. Detection of empty HLA class II molecules on cord blood B cells. Blood. 87:1996;3970.
7. Garderet L., Dulphy N., Douay C., Chalumeau N., Schaeffer V., Zilber M.T., Lim A., Even J., Mooney N., Gelin C., Gluckman E., Charron D., Toubert A. The umbilical cord blood T-cell repertoire characteristics of a polyclonal and naive but completely formed repertoire . Blood. 91:(1):1998.
8. Klas C., Debatin K.M., Jonker R.R., Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol. 5:1993;625.
9. Baker M., Altman N.H., Podack E.R., Levy R. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med. 183:1996;2645.
10. Truman J.P., Choqueux C., Tschopp J., Vedrenne J., Le Deist F., Charron D., Mooney N. HLA class II mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. Blood. 89:1997;1996.
11. Illera V.A., Perandones C.E., Stunz L.L., Mower D.A., Ashman R.F. Apoptosis in splenic B lymphocytes, regulation by protein kinase c and IL-4. J Immunol. 151:1993;2965.
12. Anel A., Simon A.K., Auphan N., Buferne M., Boyer C., Golstein P., Schmitt-Verhulst A.M. Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones. Eur J Immunol. 25:1995;3381.
13. Mossman T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assay . J Immunol Methods. 65:1983;55.
14. Seino K., Kayagaki N., Bashuda H., Okumura K., Yagita H. Contribution of Fas ligand to cardiac allograft rejection. Int Imm. 8:1996;1347.
15. Bellgrau D., Duke R.C., Franzusoff A. CD95 ligand in graft rejection. Nature. 379:1996;682.
16. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson A. Fas-ligand induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189.
17. Yagita H., Seino K., Kayagaki N., Okumura K. CD95 ligand in graft rejection. Nature. 379:1995;682.
18. Smyth M.J. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J Immunol. 158:1997;5765.
19. Arai H., Gordon D., Nabel E.G., Nabel G.J. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci. 94:1997;13862.
20. Kang S.M., Schneider D.B., Lin Z., Hanahan D., Dichek D.A., Stock P.G., Baekkeskov S. Fas ligand expression inislets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med. 3:1997;738.
21. Suda T., Hashimoto H., Tanaka M., Ochi T., Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing. J Exp Med. 186:1997;2045.
22. Fayen J., Huang J.H., Ferrone S., Tykocinski M.L. Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. Int Imm. 10:1998;1347.
23. Genestier L., Paillot R., Bonnefoy-Berard N., Meffre G., Flacher M., Fevre D., Jun Liu Y., Le Bouteiller P., Waldmann H., Engelhard V.H., Banchereau J., Revillard J.P. Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I 1 domain. Blood. 90:1997;3629.
24. Genestier L., Prigent A.-F., Paillot R., Quemeneur L., Durand I., Banchereau J., Revillard J.P., Bonnefoy-Bérard N. Caspase-dependent ceramide production in Fas- and HLA Class I-mediated peripheral T cell apoptosis. J Biol Chem. 273:1997;5060.
25. Skov S., Nielsen M., Bregenholt S., Odum N., Claesson M.H. Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood. 91:1998;3566.
26. Skov S., Bregenholt S., Claesson M.H. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3-chain and induces apoptosis. J Immunol. 158:1997;3189.
27. Woodle E.S., Smith D.M., Zhou N. Class I MHC mediates programmed cell death in human lymphoid cells. Transplantation. 64:(1):1997;140.
28. Garban F., Truman J.P., Lord J., Drenou B., Plumas J., Jacob M.C., Sotto J.J., Charron D., Mooney N. Signal transduction via human leucocyte antigen class II molecules distinguishes between cord blood, normal and malignant aduilt B lymphocytes. Exp Hem. 26:1998;874.
29. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F., Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 178:1993;2231.
30. Suzuki I., Fink P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med. 187:1997;123.